$LITE

Retort Vincent sold $2.1M of LITE

Retort Vincent (SEE REMARKS) sold 2,483 shares of Lumentum Holdings Inc. (LITE) at $827.82 ($2.06M total) on 2026-08-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Retort Vincent
Published Aug 22, 2026, 12:42 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 22, 2026, 1:07 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LITE
Bearish
medium confidence
Mentioned
$LITE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LITEBearishLow
01

Why it matters

The disclosed sale adds new information about insider sentiment for Lumentum.

02

Market read

First public disclosure of a material insider sale; may influence short‑term trading decisions.

03

What to watch

Retort Vincent retains 109,438 shares, still a sizable stake.

Relevance 5/10Novelty 7/10Timing: filed today

Background

Form 4 filings disclose insider transactions; officer sales are monitored for potential signals.

Company-level read

Ticker impact

$LITEBearishMedium confidence
Context

Officer Retort Vincent sold 2,483 shares of Lumentum for $2.06M under a pre‑arranged 10b5‑1 plan.

Expected impact

Potential short‑term pressure on LITE price, modest downside risk.

Evidence & confidence

The sale size (~$2M) is material for Lumentum and the insider is an officer; such sales often precede price weakness, though the pre‑arranged plan tempers interpretation.

Market effects

May raise questions about confidence in the photonics sector.

Limited to U.S. investors in Lumentum.

Low global impact.

Counterpoint

The sale could be routine execution of a 10b5‑1 plan, not a negative signal.

Key entities

  • Lumentum Holdings Inc.

    US‑listed photonics equipment manufacturer (ticker LITE).

  • Retort Vincent

    Company officer who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$COHRMed

Coherent Soars 6%, Lumentum Up 8% as StoneX Starts Both With Buy, Sees 103% Upside

Coherent (COHR) and Lumentum (LITE) shares rose 6% and 8% respectively after StoneX initiated coverage with Buy ratings and price targets of $425 and $1,200. StoneX cites Coherent's six-inch InP laser production and Lumentum's market position in high-speed InP lasers and cloud transceivers. Coherent's earnings estimates have been rising, with fiscal 2027 EPS expected at $9.39. StoneX's target implies a 45x multiple on fiscal 2027 earnings, above Coherent's five-year average of 24x.

$LITEHigh

What Sent Lumentum Stock Higher?

Lumentum (LITE) stock rose 8.2% on October 26, 2026, following a Buy rating and $1,200 price target from StoneX. The gain coincided with a broader rally in optical networking stocks, tied to Anthropic's IPO filing. Lumentum's revenue for fiscal Q4 2026 was $1.01 billion, up 109.3% year-over-year. The stock's movement was part of a larger sector advance, with technology stocks and peers also gaining.

High

Lumentum Stock Jumps 8% on StoneX $1,200 Target

Lumentum's stock rose 8.19% to $818.10 after StoneX initiated coverage with a Buy rating and a $1,200 price target. The company's products are used in AI and data-center infrastructure. Coherent and Applied Optoelectronics also gained. Lumentum's next earnings report is due on 5 November.

$LITEHigh

Hyperliquid’s LITE and AAOI Perpetuals Rose as Open Interest Fell

Hyperliquid perpetual contracts for LITE and AAOI rose 9.53% and 9.91% respectively, while open interest fell. StoneX initiated LITE coverage with a Buy rating and $1,200 target, citing AI-related optoelectronics demand. Open interest for LITE and AAOI dropped 21.97% and 34.61% respectively. Two large accounts closed long positions worth $2.61 million.

$LITEMed

Lumentum stock surges 10% as AI components ‘completely sold out’

Lumentum (LITE) shares rose 8% to $818 after StoneX initiated coverage with a Buy rating and $1,200 target, citing strong demand for AI-related components. Coherent (COHR) and Applied Optoelectronics (AAOI) also gained. Lumentum reported Q4 revenue of $1.01B, up 109.3% YoY, and expects Q1 2027 revenue of $1.225B-$1.275B. Nvidia (NVDA) is a major partner, committing $2B for R&D and manufacturing.

$LITEMed

Lumentum Holdings (LITE) Surges 8% on AI Infrastructure Optimism

Lumentum Holdings (LITE) shares rose 8% to $818.32 on October 26, 2026, driven by optimism about its role in AI infrastructure. StoneX initiated coverage with a Buy rating, citing strong demand for its optical technologies. The company has a P/S ratio of 23.53, significantly above its historical median, and a GF Score of 70, indicating solid financial health and growth but high valuation. Insider selling totaled $175.8 million over the past year, while institutional ownership is mixed.